Evidence map›Paper›PMID 42111641›Full record

ArticleCyborg and bionic systems (Washington, D.C.)2026

Biomimetic Microfibers for Myelin-Enhancer Screening and Neural Regeneration.

Lili Quan, Akiko Uyeda, Atsushi Sekiguchi, Ze Zhang, Kazuhisa Sakai, Tsunehiko Takamura, Ruijuan Zhang, Noritaka Ichinohe, Shinjiro Umezu, Rieko Muramatsu

Abstract read
In one paragraph

Article in Cyborg and bionic systems (Washington, D.C.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lili QuanDepartment of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Akiko UyedaDepartment of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Atsushi SekiguchiDepartment of Psychosomatic Medicine, Graduate School of Medical Sciences, Fukuoka 812-8582, Japan.
Ze ZhangDepartment of Modern Mechanical Engineering, Graduate School of Creative Science and Engineering, Waseda University, Tokyo 169-8555, Japan.
Kazuhisa SakaiDepartment of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Tsunehiko TakamuraDepartment of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Ruijuan ZhangDepartment of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Noritaka IchinoheDepartment of Ultrastructural Research, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.
Shinjiro UmezuDepartment of Modern Mechanical Engineering, Graduate School of Creative Science and Engineering, Waseda University, Tokyo 169-8555, Japan.
Rieko MuramatsuDepartment of Molecular Pharmacology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Tokyo 187-8502, Japan.ORCID https://orcid.org/0000-0001-5342-7823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Remyelination requires the precise wrapping of axons by oligodendrocyte processes, a critical step for restoring neural circuit function. However, a lack of quantitative systems that recapitulate axonal geometry and chemistry has limited mechanistic and pharmacological insights into myelin wrapping. Here, we present a bioengineered microfiber platform that mimics neurite architecture and surface chemistry, enabling high-content quantification of oligodendrocyte wrapping. Through compound screening, we identified dimemorfan, a clinically used sigma-1 receptor agonist, as a potent enhancer of myelin wrapping. Dimemorfan treatment accelerated remyelination and functional recovery in demyelinated mice and promoted myelin wrapping by human induced pluripotent stem cell (iPSC)-derived oligodendrocytes. Moreover, population-level magnetic resonance imaging (MRI) analyses revealed increased white matter volume in dimemorfan-administered individuals. This study establishes a biomimetic materials platform for myelin quantification and regeneration-oriented drug discovery, providing mechanistic and translational insights into sigma-1 receptor-mediated control of myelin wrapping.

Identifiers

PMID42111641
PMCPMC13150081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.